As COVID-19 cases surge, Washington Regional Medical Center in Fayetteville, Ark., faces growing financial and other pressures that threaten its ability to continue meeting its community’s health care needs.
Novel Coronavirus (COVID-19) News
Below are links to AHA Today stories on novel coronavirus (COVID-19). For all coronavirus resources and news updates, visit our COVID-19 page.
Latest
The AHA and its members are partnering with the Department of Health and Human Services to encourage eligible patients who recover from COVID-19 to donate convalescent plasma, which contains antibodies that could help other patients fight the virus.
The Federal Reserve issued FAQs about the Main Street Lending Program facilities for nonprofit organizations, including the Nonprofit Organization New Loan Facility and the Nonprofit Organization Expanded Loan Facility.
The Department of Health and Human Services will devote $5 billion of the Coronavirus Aid, Relief, and Economic Security Act’s Provider Relief Fund to enhance COVID-19 response at Medicare-certified long-term care facilities and state veterans’ homes, the Centers for Medicare & Medicaid Services announced.
The financial outlook for Phoenix-based Banner Health has changed dramatically since the pandemic entered their communities and forced the shutdown of non-emergency services.
The National Academies of Sciences, Engineering, and Medicine and the National Academy of Medicine July 24 will host its inaugural committee meeting on the equitable allocation of a COVID-19 vaccine.
The Coalition to Protect America’s Health Care launched a national television ad urging Congress to pass emergency funding to help provide immediate financial relief to hospitals and health systems.
The Department of Health and Humans Services said it has an agreement with Pfizer to produce and deliver 100 million doses of the drug maker’s COVID-19 vaccine candidate.
The Senate Special Committee on Aging held a hearing on the COVID-19 pandemic and seniors, which focused on racial health disparities.
The Centers for Disease Control and Prevention recently posted updated considerations for ending isolation for adults with COVID-19, based on new evidence.
When ordering COVID-19 laboratory tests or collecting specimens, health care providers should collect certain patient demographic information and responses to certain questions needed for COVID-19 data reporting, according to updated guidance from the Centers for Disease Control and Prevention.
The Department of Health and Human Services shared additional information on reporting requirements for recipients of provider relief funds authorized under the Coronavirus Aid, Relief, and Economic Security Act and Paycheck Protection Program and Health Care Enhancement Act.
Congress should allocate as part of the next COVID-19 relief package at least an additional $100 billion to the emergency relief fund to provide direct funding to front line health care personnel and providers, the AHA, American Medical Association and American Nurses Association wrote to Senate leaders.
An estimated 2.8% of Indiana residents aged 12 or older randomly tested in late April had SARS-CoV-2 infection or antibodies, and 44% of those with active infections reported no symptoms, according to a July 21 report released by the Centers for Disease Control and Prevention.
House Ways and Means Committee Ranking Member Kevin Brady, R-Texas, and Senate Finance Committee Ranking Member Ron Wyden, D-Ore., released separate legislative proposals that would make permanent certain Medicare telehealth flexibilities allowed during the COVID-19 pandemic.
A new analysis prepared for the AHA by Kaufman, Hall & Associates LLC highlights COVID-19’s dire impact on hospitals’ and health systems’ financial health.
The Food and Drug Administration last week reissued its emergency use authorization of Quest Diagnostics’ SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to four individual swab specimens collected under observation.
A COVID-19 trial vaccine developed by the University of Oxford and AstraZeneca produced neutralizing antibody responses in patients with SARS-CoV-2, according to a study published July 20 in The Lancet.
The New England Journal of Medicine last week released a study showing that the use of dexamethasone resulted in a lower, 28-day mortality rate among patients receiving invasive ventilation or oxygen.
In 2016, His Holiness the Dalai Lama and former Archbishop Desmond Tutu spent one week together in deep discussion about joy. How to obtain it and hold on to it in a changing and often chaotic world.